Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission. Read more about Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. Read more about Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Read more about Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.
Chronic granulomatous disease: lessons from a rare disorder. Read more about Chronic granulomatous disease: lessons from a rare disorder.
Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. Read more about Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia.
Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium. Read more about Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
Immunotherapy for pediatric central nervous system tumors. Read more about Immunotherapy for pediatric central nervous system tumors.
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Read more about Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation. Read more about Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. Read more about Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.
